NDC 71753-1058 Virus Defense

Echinacea (angustifolia),Glycyrrhiza Glabra,Hydrastis Canadensis,Aconitum - View Dosage, Usage, Ingredients, Routes, UNII

Product Information

NDC Product Code:
71753-1058
Proprietary Name:
Virus Defense
Non-Proprietary Name: [1]
Echinacea (angustifolia), Glycyrrhiza Glabra, Hydrastis Canadensis, Aconitum Napellus, Arsenicum Album, Belladonna, Bryonia (alba), Eupatorium Perfoliatum, Gelsemium Sempervirens, Lachesis Mutus, Rhus Tox, Pyrogenium
Substance Name: [2]
Aconitum Napellus Whole; Arsenic Trioxide; Atropa Belladonna; Bryonia Alba Root; Echinacea Angustifolia Whole; Eupatorium Perfoliatum Flowering Top; Gelsemium Sempervirens Root; Glycyrrhiza Glabra; Goldenseal; Lachesis Muta Venom; Rancid Beef; Toxicodendron Pubescens Leaf
NDC Directory Status:
Human Otc Drug
Product Type: [3]
ACTIVE PRODUCT INCLUDED in the NDC Directory
Dosage Form:
Spray - A liquid minutely divided as by a jet of air or steam.
Administration Route(s): [4]
  • Oral - Administration to or by way of the mouth.
  • Labeler Name: [5]
    Ratis, Llc
    Labeler Code:
    71753
    Marketing Category: [8]
    UNAPPROVED HOMEOPATHIC - A category specifying that a product is marketed as unapproved homeopathic product.
    Start Marketing Date: [9]
    04-22-2020
    End Marketing Date: [10]
    09-15-2025
    Exclude Flag: [12]
    N
    Code Structure:
    Code Navigator:

    Product Packages

    NDC Code 71753-1058-1

    Package Description: 30 mL in 1 BOTTLE, SPRAY

    Product Details

    What is NDC 71753-1058?

    The NDC code 71753-1058 is assigned by the FDA to the product Virus Defense which is a human over the counter drug product labeled by Ratis, Llc. The generic name of Virus Defense is echinacea (angustifolia), glycyrrhiza glabra, hydrastis canadensis, aconitum napellus, arsenicum album, belladonna, bryonia (alba), eupatorium perfoliatum, gelsemium sempervirens, lachesis mutus, rhus tox, pyrogenium. The product's dosage form is spray and is administered via oral form. The product is distributed in a single package with assigned NDC code 71753-1058-1 30 ml in 1 bottle, spray . This page includes all the important details about this product, including active and inactive ingredients, pharmagologic classes, product uses and characteristics, UNII information and RxNorm crosswalk.

    What are the uses for Virus Defense?

    Adults: 2 sprays 3 times a day or as needed.Children 2-12: 1 spray as above. For children under 2, consult a doctor.

    What are Virus Defense Active Ingredients?

    An active ingredient is the substance responsible for the medicinal effects of a product specified by the substance's molecular structure or if the molecular structure is not known, defined by an unambiguous definition that identifies the substance. Each active ingredient name is the preferred term of the UNII code submitted.

    Which are Virus Defense UNII Codes?

    The UNII codes for the active ingredients in this product are:

    Which are Virus Defense Inactive Ingredients UNII Codes?

    The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:

    Which are the Pharmacologic Classes for Virus Defense?

    A pharmacologic class is a group of drugs that share the same scientifically documented properties. The following is a list of the reported pharmacologic class(es) corresponding to the active ingredients of this product.

    * Please review the disclaimer below.

    Product Footnotes

    [1] What is the Non-Proprietary Name? - The non-proprietary name is sometimes called the generic name. The generic name usually includes the active ingredient(s) of the product.

    [2] What is the Substance Name? - An active ingredient is the substance responsible for the medicinal effects of a product specified by the substance's molecular structure or if the molecular structure is not known, defined by an unambiguous definition that identifies the substance. Each active ingredient name is the preferred term of the UNII code submitted.

    [3] What kind of product is this? - Indicates the type of product, such as Human Prescription Drug or Human Over the Counter Drug. This data element matches the “Document Type” field of the Structured Product Listing.

    [4] What are the Administration Routes? - The translation of the route code submitted by the firm, indicating route of administration.

    [5] What is the Labeler Name? - Name of Company corresponding to the labeler code segment of the Product NDC.

    [8] What is the Marketing Category? - Product types are broken down into several potential Marketing Categories, such as NDA/ANDA/BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.

    [9] What is the Start Marketing Date? - This is the date that the labeler indicates was the start of its marketing of the drug product.

    [10] What is the End Marketing Date? - This is the date the product will no longer be available on the market. If a product is no longer being manufactured, in most cases, the FDA recommends firms use the expiration date of the last lot produced as the EndMarketingDate, to reflect the potential for drug product to remain available after manufacturing has ceased. Products that are the subject of ongoing manufacturing will not ordinarily have any EndMarketingDate. Products with a value in the EndMarketingDate will be removed from the NDC Directory when the EndMarketingDate is reached.

    [12] What is the NDC Exclude Flag? - This field indicates whether the product has been removed/excluded from the NDC Directory for failure to respond to FDA"s requests for correction to deficient or non-compliant submissions ("Y"), or because the listing certification is expired ("E"), or because the listing data was inactivated by FDA ("I"). Values = "Y", "N", "E", or "I".